4D MOLECULAR THERAPEUTICS IN shareholders Q2 2023

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.

4D MOLECULAR THERAPEUTICS IN shareholders Q2 2023
NameSharesValueWeighting ↓
METROPOLITAN LIFE INSURANCE CO/NY 1,762$31,8390.00%
STATE OF WISCONSIN INVESTMENT BOARD 35,065$633,6250.00%
DIMENSIONAL FUND ADVISORS LP 431,111$7,790,1750.00%
AMERICAN INTERNATIONAL GROUP, INC. 15,201$274,6820.00%
Connor, Clark & Lunn Investment Management Ltd. 21,824$394,3600.00%
M&T BANK CORP 28,814$520,3340.00%
Ameritas Investment Partners, Inc. 2,608$47,1270.00%
Tower Research Capital LLC (TRC) 3,032$54,7880.00%
BARCLAYS PLC 142,464$2,5740.00%
MetLife Investment Management, LLC 17,379$314,0390.00%
STATE STREET CORP 2,050,430$37,051,2700.00%
MILLENNIUM MANAGEMENT LLC 278,701$5,036,1270.00%
GOLDMAN SACHS GROUP INC 194,265$3,510,3690.00%
JPMORGAN CHASE & CO 457,214$8,261,8570.00%
VANGUARD GROUP INC 1,973,102$35,653,9520.00%
Mirae Asset Global Investments Co., Ltd. 20,290$364,7960.00%
Swiss National Bank 61,600$1,113,1120.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 35,596$643,2200.00%
ALLIANCEBERNSTEIN L.P. 88,640$1,601,7250.00%
RHUMBLINE ADVISERS 48,988$885,2130.00%
External links

This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.